Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC has issued several clarifications and enforcement actions, including a retraction of a public alert on Deleject needles, a blacklisting of Onifam Laboratories, and guidance on handling manufacturer investigation reports for medical devices. These updates signal a tightening of regulatory oversight in the pharmaceutical and medical device sectors, emphasizing compliance and transparency. Businesses should review their regulatory submissions and ensure adherence to NAFDAC standards to avoid penalties.
Pharmaceuticals
Medical Devices
Food Safety
Healthcare
Export/Import
Regulatory Clarification on Deleject Disposable Needle Public Alert No. 042/2026
NAFDAC
NAFDAC clarified that the public alert about particulate matter in Deleject needles was uploaded in error and the issue was resolved after review.
Businesses dealing with medical devices should ensure they verify NAFDAC alerts and clarifications to avoid unnecessary product recalls or reputational damage.
2026 World Breastfeeding Week Capacity Building Event for Healthcare Professionals
NAFDAC
NAFDAC hosted a capacity building event for healthcare professionals to promote breastfeeding, emphasizing the importance of nutrition and food safety.
SMBs in food and nutrition sectors may see increased demand for breastfeeding-friendly products and should align with NAFDAC's nutrition guidelines.
NAFDAC joins the Federal Ministry of Health and Social Welfare, nutrition partners, and the global community in celebrating World Breastfeeding Week 2026
NAFDAC
NAFDAC participated in World Breastfeeding Week, highlighting its commitment to maternal and child health.
This reinforces NAFDAC's focus on nutrition and may lead to stricter regulations on infant formula and complementary foods.
Handling Manufacturer Investigation Reports for Medical Devices and IVDs
NAFDAC
NAFDAC issued guidance on handling Manufacturer Investigation Reports (MIRs) for medical devices and IVDs to ensure proper assessment of complaints and adverse events.
Medical device manufacturers and importers must establish robust procedures for handling MIRs to comply with NAFDAC requirements and avoid regulatory action.
Blacklisting of Onifam Laboratories Ltd
NAFDAC
NAFDAC blacklisted Onifam Laboratories Ltd for regulatory misrepresentation and improper use of approvals, barring them from pharmaceutical business activities.
This serves as a warning to pharmaceutical companies to maintain integrity in regulatory submissions; non-compliance can lead to severe penalties including blacklisting.
SON rides on e-platform to facilitate international trade - Business News Nigeria
Other
SON is using an electronic platform to facilitate international trade, streamlining processes for exporters and importers.
SMBs involved in international trade should leverage SON's e-platform to expedite certifications and reduce delays.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide - within nigeria
Other
A guide on registering fish farms with NEPC for export purposes, highlighting the process and benefits.
Fish farmers looking to export should follow NEPC registration guidelines to access international markets and incentives.
Increased scrutiny on pharmaceutical and medical device compliance
Emphasis on transparency and integrity in regulatory submissions
Opportunities in nutrition and breastfeeding-related products
Digitalization of trade facilitation processes
Need for robust adverse event reporting systems
1
Review and update internal procedures for handling manufacturer investigation reports
2
Verify the authenticity of NAFDAC alerts and clarifications before acting
3
Ensure all regulatory submissions are accurate and truthful to avoid blacklisting
4
Align product portfolios with NAFDAC's nutrition and food safety guidelines
5
Utilize SON's e-platform for faster trade documentation
6
Register with NEPC for fish farming exports to access global markets